insulin

Lantus is being replaced

Lantus is a long-acting basal insulin which has been around since 2000. That’s about to change, but don’t panic. Essentially it’s just a name change. History Lantus is a U100 form of insulin glargine, made by Sanofi. Its patent protection eventually ran out, so new versions started appearing from other companies. Lilly (who also make Humalog) …

Lantus is being replaced Read More »

Revisiting Fiasp

Fiasp insulin became available on the Australian PBS in June this year. Based on feedback from users overseas, I was prepared to encounter issues with trying to use it. I last wrote about my use of it in “Fiaspro” which seemed to be going fairly well. This article is a followup to that. Fiaspro I ended …

Revisiting Fiasp Read More »

Another insulin – October 2019

In the October update to the Australian PBS (Pharmaceutical Benefits Scheme), another insulin arrived today. Well, sort of. The addition is Semglee, which is a “biosimilar equivalent” to Lantus. Like Lantus it’s insulin glargine. Lantus is one of the commonly-used long-acting (or “basal”) insulin used for daily injections. It’s been around for years (I used …

Another insulin – October 2019 Read More »

Using Fiasp in a pump

There still seems to be some confusion in the community about whether the new Fiasp insulin should be used in a pump. Also confusion amongst the pump sales/support staff! The regulatory position is that while in the USA it is not approved for use in a pump, it is approved in both Australia and Europe. …

Using Fiasp in a pump Read More »